Scholtes RA, Mosterd CM, Hesp AC, Smits MM, et al. Mechanisms underlying the blood pressure lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: a secondary analysis of a randomized cross-over trial. Diabetes Obes Metab 2022 Sep 11. doi: 10.1111/dom.14864.
PMID: 36089810